Table of Contents
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL C REACTIVE PROTEIN TESTING MARKET, BY Assay Type
6.1. Overview
6.2. Enzyme-linked immunosorbent assay (ELISA)
6.3. Chemiluminescence Immunoassay (CLIA)
6.4. Immunoturbidimetric assays
7. GLOBAL C REACTIVE PROTEIN TESTING MARKET, BY Application
7.1. Diabetes
7.2. Rheumatoid Arthritis
7.3. Cardiovascular Disease
7.4. Inflammatory Bowel Disease
7.5. Others
8. GLOBAL C REACTIVE PROTEIN TESTING MARKET, by Region
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. Competitive Landscape
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global C reactive protein testing Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global C reactive protein testing Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2022
9.8.2. Major Players R&D Expenditure. 2022
10. Company ProfileS
10.1. Randox Laboratories Limited
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Merck KGAA (Millipore Sigma)
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Quest Diagnostics Incorporated
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Abbott Laboratories
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Zoetis Inc. (Abaxis Inc.)
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Thermo Fisher Scientific
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Danaher Corporation (Beckman Coulter Inc.)
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. HORIBA, LTD
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. F. Hoffmann-La Roche AG
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Laboratory Corporation of America Holdings
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
11. Appendix
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 Global C reactive protein testing Market, Synopsis, 2018-2032
TABLE 2 Global C reactive protein testing Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 5 North America: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 6 North America: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 7 US: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 8 US: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 9 Canada: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 10 Canada: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 1 Europe: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 2 Europe: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 3 germany: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 4 germany: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 5 FRANCE: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 6 FRANCE: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 7 italy: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 8 italy: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 9 spain: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 10 spain: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 11 UK: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 12 UK: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 13 rest of europe: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 14 rest of europe: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 15 Asia-Pacific: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 16 Asia-Pacific: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 17 japan: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 18 japan: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 19 japan: C REACTIVE PROTEIN TESTING MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 20 china: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 21 china: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 22 india: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 23
TABLE 24 india: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 25 australia: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 26 australia: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 27 south korea: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 28 south korea: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 29 rest of asia-pacific: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 30 rest of asia-pacific: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 31 rest of the world: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 32 rest of the world: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 33 Middle east: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 34 Middle east: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 35 Africa: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 36 Africa: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 37 Latin america: C REACTIVE PROTEIN TESTING MARKET, BY Assay Type, 2018-2032 (USD BILLION)
TABLE 38 Latin america: C REACTIVE PROTEIN TESTING MARKET, BY Application, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global C reactive protein testing Market
FIGURE 3 Market Dynamics for the Global C reactive protein testing Market
FIGURE 4 Global C reactive protein testing Market, Share (%), BY Assay Type, 2022
FIGURE 5 Global C reactive protein testing Market, Share (%), BY Application, 2022
FIGURE 6 Global C reactive protein testing Market, Share (%), by Region, 2022
FIGURE 7 north AMERICA: C REACTIVE PROTEIN TESTING MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 Europe: C REACTIVE PROTEIN TESTING MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 Asia-Pacific: C REACTIVE PROTEIN TESTING MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Rest of the world: C REACTIVE PROTEIN TESTING MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Global C reactive protein testing Market: Company Share Analysis, 2022 (%)
FIGURE 12 Randox Laboratories Limited: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 Randox Laboratories Limited: SWOT ANALYSIS
FIGURE 14 MERCK KGAA (MILLIPORE SIGMA): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 MERCK KGAA (MILLIPORE SIGMA): SWOT ANALYSIS
FIGURE 16 Quest Diagnostics Incorporated: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 Quest Diagnostics Incorporated: SWOT ANALYSIS
FIGURE 18 Abbott Laboratories: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 Abbott Laboratories: SWOT ANALYSIS
FIGURE 20 ZOETIS INC. (ABAXIS INC.).: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 ZOETIS INC. (ABAXIS INC.).: SWOT ANALYSIS
FIGURE 22 Thermo Fisher Scientific: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 Thermo Fisher Scientific: SWOT ANALYSIS
FIGURE 24 Danaher Corporation (Beckman Coulter Inc.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 Danaher Corporation (Beckman Coulter Inc.): SWOT ANALYSIS
FIGURE 26 HORIBA, LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 HORIBA, LTD: SWOT ANALYSIS
FIGURE 28 F. Hoffmann-La Roche AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 F. Hoffmann-La Roche AG: SWOT ANALYSIS
FIGURE 30 Laboratory Corporation of America Holdings: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 Laboratory Corporation of America Holdings: SWOT ANALYSIS